Evolution of radiopharmaceuticals for diagnosis and therapy
β Scribed by Susan Z. Lever
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 69 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
β¦ Synopsis
Diagnostic radiopharmaceuticals should reflect in vivo biochemistry. Therapeutic radiopharmaceuticals should kill tumor cells while sparing healthy cells. As the understanding of a biological process increases, synthetic chemists must be ever poised to improve the design of new radiotracers to reflect the in vivo scenario in an accurate and precise fashion. However, it is somewhat ironic that, due to genetic variability, there is an inverse relationship between the specificity of the radiotracer and the number of individuals who will eventually be helped by these discoveries. Regardless of the beauty of the science that underpins radiopharmaceutical development, the availability of financial resources will direct the overall progress in the field.
π SIMILAR VOLUMES
## Abstract According to the recently revised nomenclature for allergy [1] the term βFood Hypersensitivityβ is proposed to define a reaction on food exposure causing objectively reproducible symptoms or signs at a dose tolerated by normal subjects. Those reactions to food in which immunologic mecha
## Abstract Zenker's diverticulum is a rare anatomic defect that physicians have confronted for almost 250 years. Its location at the interface of the pharynx, neck, and mediastinum makes surgical access difficult and risks severe morbidity. Minimally invasive endoscopic surgical repair of Zenker's
## Abstract Postβtranslational modifications (PTMs) of nuclear proteins play essential roles in the regulation of gene transcription and signal transduction pathways. Numerous studies have demonstrated a correlation between specific nuclear protein isoforms and cellular malignant process. This comm